甲状腺癌诊疗规范(2018年版)

2018-12-13 中华人民共和国国家卫生健康委员会 中华人民共和国国家卫生健康委员会官网

甲状腺癌(Thyroid Cancer)是一种起源于甲状腺滤泡上皮或滤泡旁上皮细胞的恶性肿瘤,也是头颈部最为常见的恶性肿瘤。近年来,全球范围内甲状腺癌的发病率增长迅速,据全国肿瘤登记中心的数据显示,我国城市地区女性甲状腺癌发病率位居女性所有恶性肿瘤的第4位。我国甲状腺癌将以每年20%的速度持续增长。

中文标题:

甲状腺癌诊疗规范(2018年版)

发布日期:

2018-12-13

简要介绍:

甲状腺癌(Thyroid Cancer)是一种起源于甲状腺滤泡上皮或滤泡旁上皮细胞的恶性肿瘤,也是头颈部最为常见的恶性肿瘤。近年来,全球范围内甲状腺癌的发病率增长迅速,据全国肿瘤登记中心的数据显示,我国城市地区女性甲状腺癌发病率位居女性所有恶性肿瘤的第4位。我国甲状腺癌将以每年20%的速度持续增长。 

拓展指南:甲状腺癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=甲状腺癌诊疗规范(2018年版))] GetToolGuiderByIdResponse(projectId=1, id=36b0d1c0016812e1, title=甲状腺癌诊疗规范(2018年版), enTitle=, guiderFrom=中华人民共和国国家卫生健康委员会官网, authorId=null, author=, summary=甲状腺癌(Thyroid Cancer)是一种起源于甲状腺滤泡上皮或滤泡旁上皮细胞的恶性肿瘤,也是头颈部最为常见的恶性肿瘤。近年来,全球范围内甲状腺癌的发病率增长迅速,据全国肿瘤登记中心的数据显示,我国城市地区女性甲状腺癌发病率位居女性所有恶性肿瘤的第4位。我国甲状腺癌将以每年20%的速度持续增长。 , cover=, journalId=null, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Dec 13 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>甲状腺癌(Thyroid Cancer)是一种起源于甲状腺滤泡上皮或滤泡旁上皮细胞的恶性肿瘤,也是头颈部最为常见的恶性肿瘤。近年来,全球范围内甲状腺癌的发病率增长迅速,据全国肿瘤登记中心的数据显示,我国城市地区女性甲状腺癌发病率位居女性所有恶性肿瘤的第4位。我国甲状腺癌将以每年20%的速度持续增长。 </div> <div><br> </div> 拓展指南:<strong>与<font color=red>甲状腺癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=ddb0c1c0016e031b" title="NCCN临床实践指南:甲状腺癌(2018.V2)" target=_blank>NCCN临床实践指南:甲状腺癌(2018.V2)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a454b1c001630ab3" title="2018 波兰国家指南:甲状腺癌的诊断和治疗(更新版)" target=_blank>2018 波兰国家指南:甲状腺癌的诊断和治疗(更新版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c5a861c00159e7e3" title="NCCN临床实践指南:甲状腺癌(2018.V1)" target=_blank>NCCN临床实践指南:甲状腺癌(2018.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=997911c001590afe" title="2018 意大利共识:分化型甲状腺癌的诊断和治疗" target=_blank>2018 意大利共识:分化型甲状腺癌的诊断和治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=415781c001566a6f" title="甲状腺癌血清标志物临床应用专家共识(2017 版)" target=_blank>甲状腺癌血清标志物临床应用专家共识(2017 版)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%94%B2%E7%8A%B6%E8%85%BA%E7%99%8C" target=_blank>有关甲状腺癌更多指南</a></ul>, tagList=[TagDto(tagId=865, tagName=甲状腺癌), TagDto(tagId=540, tagName=诊疗规范)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=28526, appHits=2373, showAppHits=101, pcHits=8357, showPcHits=20665, likes=201, shares=98, comments=36, approvalStatus=1, publishedTime=Fri Dec 28 00:56:20 CST 2018, publishedTimeString=2018-12-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Dec 28 00:56:20 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:19:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=甲状腺癌诊疗规范(2018年版))])
甲状腺癌诊疗规范(2018年版)
下载请点击:
评论区 (31)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1226558, encodeId=0c611226558ac, content=受教, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210106/9af9417adfb649d799961d6c92a6a9ea/a1b49bb268d24cfaa1477a74f671adce.jpg, createdBy=73ac5216709, createdName=1476f713m89暂无昵称, createdTime=Wed Jun 15 11:02:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061109, encodeId=bd531061109d7, content=cool , beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/02660cb65ca24ecd8c4895ccd3e47bea/94e7443e6f234495b8c9b1ae1dc0c15a.jpg, createdBy=0d661666123, createdName=drzty, createdTime=Sat Oct 16 21:44:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012437, encodeId=4a54101243e7c, content=aa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15ab5545752, createdName=ms5000000668334664, createdTime=Sun Aug 29 00:59:31 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000857, encodeId=4441100085e39, content=有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Mon Jul 19 12:55:02 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000856, encodeId=3a571000856f3, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Mon Jul 19 12:54:49 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2022-06-15 1476f713m89暂无昵称

    受教

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1226558, encodeId=0c611226558ac, content=受教, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210106/9af9417adfb649d799961d6c92a6a9ea/a1b49bb268d24cfaa1477a74f671adce.jpg, createdBy=73ac5216709, createdName=1476f713m89暂无昵称, createdTime=Wed Jun 15 11:02:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061109, encodeId=bd531061109d7, content=cool , beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/02660cb65ca24ecd8c4895ccd3e47bea/94e7443e6f234495b8c9b1ae1dc0c15a.jpg, createdBy=0d661666123, createdName=drzty, createdTime=Sat Oct 16 21:44:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012437, encodeId=4a54101243e7c, content=aa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15ab5545752, createdName=ms5000000668334664, createdTime=Sun Aug 29 00:59:31 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000857, encodeId=4441100085e39, content=有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Mon Jul 19 12:55:02 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000856, encodeId=3a571000856f3, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Mon Jul 19 12:54:49 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-10-16 drzty

    cool

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1226558, encodeId=0c611226558ac, content=受教, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210106/9af9417adfb649d799961d6c92a6a9ea/a1b49bb268d24cfaa1477a74f671adce.jpg, createdBy=73ac5216709, createdName=1476f713m89暂无昵称, createdTime=Wed Jun 15 11:02:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061109, encodeId=bd531061109d7, content=cool , beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/02660cb65ca24ecd8c4895ccd3e47bea/94e7443e6f234495b8c9b1ae1dc0c15a.jpg, createdBy=0d661666123, createdName=drzty, createdTime=Sat Oct 16 21:44:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012437, encodeId=4a54101243e7c, content=aa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15ab5545752, createdName=ms5000000668334664, createdTime=Sun Aug 29 00:59:31 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000857, encodeId=4441100085e39, content=有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Mon Jul 19 12:55:02 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000856, encodeId=3a571000856f3, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Mon Jul 19 12:54:49 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-08-29 ms5000000668334664

    aa

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1226558, encodeId=0c611226558ac, content=受教, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210106/9af9417adfb649d799961d6c92a6a9ea/a1b49bb268d24cfaa1477a74f671adce.jpg, createdBy=73ac5216709, createdName=1476f713m89暂无昵称, createdTime=Wed Jun 15 11:02:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061109, encodeId=bd531061109d7, content=cool , beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/02660cb65ca24ecd8c4895ccd3e47bea/94e7443e6f234495b8c9b1ae1dc0c15a.jpg, createdBy=0d661666123, createdName=drzty, createdTime=Sat Oct 16 21:44:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012437, encodeId=4a54101243e7c, content=aa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15ab5545752, createdName=ms5000000668334664, createdTime=Sun Aug 29 00:59:31 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000857, encodeId=4441100085e39, content=有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Mon Jul 19 12:55:02 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000856, encodeId=3a571000856f3, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Mon Jul 19 12:54:49 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-07-19 yesaisai133

    有帮助

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1226558, encodeId=0c611226558ac, content=受教, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210106/9af9417adfb649d799961d6c92a6a9ea/a1b49bb268d24cfaa1477a74f671adce.jpg, createdBy=73ac5216709, createdName=1476f713m89暂无昵称, createdTime=Wed Jun 15 11:02:09 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061109, encodeId=bd531061109d7, content=cool , beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/02660cb65ca24ecd8c4895ccd3e47bea/94e7443e6f234495b8c9b1ae1dc0c15a.jpg, createdBy=0d661666123, createdName=drzty, createdTime=Sat Oct 16 21:44:58 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012437, encodeId=4a54101243e7c, content=aa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15ab5545752, createdName=ms5000000668334664, createdTime=Sun Aug 29 00:59:31 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000857, encodeId=4441100085e39, content=有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Mon Jul 19 12:55:02 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000856, encodeId=3a571000856f3, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Mon Jul 19 12:54:49 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-07-19 yesaisai133

    很有帮助

    0